Leukotriene modifiers: new drugs, old and new reactions

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):374-5. doi: 10.1016/s0091-6749(99)70459-8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acetates / adverse effects*
  • Acetates / therapeutic use
  • Anti-Asthmatic Agents / adverse effects*
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / complications
  • Asthma / drug therapy
  • Autoimmune Diseases / chemically induced
  • Chromones / adverse effects*
  • Chromones / therapeutic use
  • Churg-Strauss Syndrome / chemically induced
  • Cyclopropanes
  • Drug Hypersensitivity / etiology
  • Eosinophilia / chemically induced
  • Humans
  • Indoles
  • Leukotriene Antagonists / adverse effects*
  • Leukotriene Antagonists / therapeutic use
  • Leukotrienes / physiology*
  • Lupus Erythematosus, Systemic / chemically induced
  • Phenylcarbamates
  • Quinolines / adverse effects*
  • Quinolines / therapeutic use
  • Sulfides
  • Sulfonamides
  • Th2 Cells / immunology
  • Tosyl Compounds / adverse effects*
  • Tosyl Compounds / therapeutic use

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Chromones
  • Cyclopropanes
  • Indoles
  • Leukotriene Antagonists
  • Leukotrienes
  • Phenylcarbamates
  • Quinolines
  • Sulfides
  • Sulfonamides
  • Tosyl Compounds
  • montelukast
  • pranlukast
  • zafirlukast